REVELATION BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REVELATION BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $100.00K, a 299.99% increase year-over-year.
- REVELATION BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $25.00K.
- REVELATION BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2021 was $100.00K, a 299.99% increase from fiscal 2020.
- REVELATION BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2020 was $25.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $100.00K 10-K · filed 2023-03-30 | |
| 2021-03-31 | $100.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $25.00K 10-K/A · filed 2021-06-16 | |
| 2020-03-31 | $25.00K 10-Q · filed 2021-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |